Megan Wind-Rotolo

9PUBLICATIONS
62CO-AUTHORS
HaematologyMolecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 08, 2024
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.

Eduard J van Beers, Hanny Al-Samkari, Rachael F Grace

|Mar 19, 2022
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma.

Robert J Motzer, Toni K Choueiri, David F McDermott

|Feb 08, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumab.

Kathleen M Mahoney, Petra Ross-Macdonald, Long Yuan

|Aug 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma.

F Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf

|Apr 10, 2021
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing.

Li Wang, John P Sfakianos, Kristin G Beaumont

|Mar 04, 2021
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.

Petra Ross-Macdonald, Alice M Walsh, Scott D Chasalow

Pageof 2